Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Haemonetics has an RSI value of 25.47, indicating oversold conditions. The stock is down 19% over the past month, indicating a bearish trend. Haemonetics posted better-than-expected quarterly earnings on Aug. 8. Current share price is $73.99, near its 52-week low of $70.74. Investment opportunity exists due to the oversold status of HAE.
- Haemonetics has an RSI value of 25.47, indicating oversold conditions.
- The stock is down 19% over the past month, indicating a bearish trend.
- Haemonetics posted better-than-expected quarterly earnings on Aug. 8.
- Current share price is $73.99, near its 52-week low of $70.74.
- Investment opportunity exists due to the oversold status of HAE.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.